Previous study reported that FTO was highly expressed and functioned as an oncogene in certain subtypes of acute myeloid leukemia (AML) by targeting ASB2 and RARA through mRNA demethylation (18). The gene discussed is FTO; the disease is acute myeloid leukemia.